Companies / BOC Sciences / obiltoxaximab
BOC Sciences

obiltoxaximab | BOC Sciences

Obiltoxaximab is a monoclonal antibody developed for the treatment of exposure to Bacillus anthracis spores. It may cause allergic reactions, including anaphylaxis.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.